Aug 2016
Financial Adviser
USD 125 million
Acquisition of the North American rights to RUCONEST
Pharming
Pharming is a public biotech company developing innovative products for the treatment of unmet medical needs
Pharming is a public biotech company developing innovative products for the treatment of unmet medical needs